CHANDAN Q4 FY26 Earnings Call Transcript & Analysis
FY26 Revenue ₹281 cr (+20% YoY); FY26 EBITDA ₹57 cr (+31% YoY); FY26 EBITDA Margin 20.25%. Q4 FY26 Revenue at INR 77.41 crores, up 18.96% YoY.
Read full transcript & analysis
Every earnings call for CHANDAN — management tone, guidance, KPIs and promise tracking, quarter by quarter.
CHANDAN · 3 transcripts · Healthcare · latest Q4 FY26Chandan Healthca has 3 earnings calls on record here, a Healthcare company, most recently Q4 FY26. Each quarter is scored on revenue, margins, guidance delivery and the questions management left unanswered — so the gap between what was promised and what was delivered is easy to read.
FY26 Revenue ₹281 cr (+20% YoY); FY26 EBITDA ₹57 cr (+31% YoY); FY26 EBITDA Margin 20.25%. Q4 FY26 Revenue at INR 77.41 crores, up 18.96% YoY.
Read full transcript & analysisRevenue ₹66 cr (+20% YoY); EBITDA ₹13 cr (+39% YoY); EBITDA Margin 19.17% (+3% YoY). Revenue of ₹65.77 crores, up 20% YoY.
Read full transcript & analysisEBITDA ₹30 cr (+44% YoY); EBITDA Margin 21.81%; PAT ₹16 cr (+47% YoY). Revenue of ₹137.49 crores, up 23.38% YoY.
Read full transcript & analysis